Cargando…
Lifeday coverage of oral anticoagulants and one-year relative survival in patients with atrial fibrillation: a population-based study in Estonia
BACKGROUND: Routine oral anticoagulation (OAC) is recommended for almost all high-risk patients with atrial fibrillation, yet registries show that OACs are still underused. Our aim was to study the lifeday coverage (LDC) of OAC prescriptions and its relationship with one-year mortality rates of AF p...
Autores principales: | Pauklin, Priit, Marandi, Toomas, Kals, Mart, Ainla, Tiia, Martinson, Katrin, Eha, Jaan, Kampus, Priit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422845/ https://www.ncbi.nlm.nih.gov/pubmed/37568101 http://dx.doi.org/10.1186/s12872-023-03415-4 |
Ejemplares similares
-
Markers of Inflammation, Oxidative Stress, and Fibrosis in Patients with Atrial Fibrillation
por: Pauklin, Priit, et al.
Publicado: (2022) -
Atrial fibrillation is associated with increased central blood pressure and arterial stiffness
por: Pauklin, Priit, et al.
Publicado: (2021) -
Adherence to recommendations for secondary prevention medications after myocardial infarction in Estonia: comparison of real-world data from 2004 to 2005 and 2017 to 2018
por: Lõiveke, Piret, et al.
Publicado: (2021) -
Improved treatment and prognosis after acute myocardial infarction in Estonia: cross-sectional study from a high risk country
por: Saar, Aet, et al.
Publicado: (2015) -
Use of evidence-based pharmacotherapy after myocardial infarction in Estonia
por: Marandi, Toomas, et al.
Publicado: (2010)